You searched for "MMC"
Meltdown, Spectre, Flying Hospitals and Spy Cams
1 April 2018
| David Haider
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
iPhone slowdown In early 2018 users discovered that Apple was slowing down older iPhones intentionally. The reported reason was to prolong the usable battery life. These changes were made without the knowledge or consent of owners. Unsurprisingly, a community backlash...
Protecting retinal ganglion cells
1 August 2017
| Sofia Rokerya
|
EYE - Glaucoma
Glaucoma is considered to be a heterogeneous group of conditions giving retinal ganglion cells (RGC) damage. Lowering intraocular pressure (IOP) reduces the risk of progressive RGC loss in glaucoma. Regeneration of the optic nerve has been shown to restore some...
University of Edinburgh online ophthalmology applications deadline approaches
20 August 2020
The deadline is approaching for applications to the MSc (Master of Science) in Primary Care Ophthalmology and ChM (Master of Surgery) in Clinical Ophthalmology at the University of Edinburgh. Enhance your ophthalmic knowledge and clinical practice with world class postgraduate...
New speaker for the SEE Summit
The Association of British Dispensing Opticians (ABDO) has announced another speaker for the SEE Summit. Former GP Dr Matt Sawyer runs an environmental sustainability consultancy, SEE Sustainability, working to improve human and planetary health.The College of Optometrists appoints Chris Steele FCOptom as Clinical Editor of Acuity
24 March 2025
|
The College of Optometrists, ophthalmology, Acuity, Clinical Editor, appointments, optometry
The College of Optometrists has appointed Chris Steele FCOptom, DCLP, DipOC, DipTp(IP), FBCLA as the new Clinical Editor of Acuity, the College’s award-winning professional development journal. Chris joins Acuity from his role as Consultant Hospital Optometrist and Head of Optometry...
Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...A novel integrated practice unit (IPU) approach to periocular skin cancer management
The COVID-19 pandemic was one of the biggest challenges to face NHS workers. However, history has repeatedly shown that times of difficulty can result in the development of significant social and technological advances. We describe our own experience of this...International medical graduates in ophthalmology
4 December 2023
| Abdelrahman Obiedat
|
EYE - General
IMGs in the NHS The General Medical Council (GMC) defines an international medical graduate (IMG) as someone who has obtained their primary medical qualification outside the European Economic Area (EEA) [1], meaning that an IMG is a medical doctor whose...
Licence to save: a UK survey of anti-VEGF use for the eye
1 February 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
Moorfields to start new retinal detachment clinical trial
8 November 2023
|
Moorfields, Funding, Phase I trial, Mahi Muqit, retinal detachment, proliferative vitreoretinopathy
Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.
Demystifying external trainee selected components and out of programme experiences
3 February 2023
| Hari Kaneshayogan
|
EYE - General
If you don’t know your external TSCs from your OOPC/OOPT/OOPE/OOPR, then this article is for you. Trainee selected components (TSC) are College-approved periods of training, usually ranging from six months to a year (formally ASTO) of intensive subspecialty training in...
